Scienture Holdings (SCNX) Biznesning o‘zini qoplash muddati

Scienture Holdings Inc. (SCNX) korporativ emblemasi va logotipi

Scienture Holdings Inc (SCNX) surunkali kasalliklar bilan kasallangan bemorlar uchun qulaylikni oshirish maqsadida dori vositalarini yetkazib berish usullarini modernizatsiya qilishga e'tibor qaratadi. Sahifada mavjud bo'lgan narx vizualizatsiyasi P/E koeffitsiyenti -0.20 ekanligini ko'rsatmoqda. Aktiv dinamikasi klinik sinovlarning muvaffaqiyati va mahsulotlarning tijoratga chiqarilishiga bog'liq bo'lib, bu biznesni bozor pasayishlaridan mustaqil qiladi. Kompaniyaga tegishli rivojlanish sun'iy intellektni bulutli farmatsevtika tahlil tizimlariga integratsiya qilishga asoslangan.

P/E multiplikatori: Scienture (SCNX) 24.09.2024 - 16.11.2026 uchun

Scienture Holdings Inc kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning umumiy tahlili:Scienture Holdings Inc., SCNX
scienture.com original mahsuloti

Uzoq muddatli portfelni shakllantirishda haddan tashqari ko'p to'lash xavfini minimallashtirish uchun Scienture Holdings Inc. (SCNX) kompaniyasining joriy P/E koeffitsiyentini tahlil qilish juda muhimdir, chunki u bozor kapitalizatsiyasining sof foydaga nisbatini hisoblagan holda investitsiyalarning qoplanish muddatini belgilaydi. Farmatsevtika laboratoriyalaridagi dasturiy ta'minotni almashtirishning yuqori xarajatlari va Scienture Holdings Inc. yechimlarining patent himoyasi barqaror pul oqimini ta'minlaydi, bu esa ushbu koeffitsiyentni biznesning fundamental barqarorligining ishonchli ko'rsatkichi qiladi.

Raqobatdosh kompaniyalar

Narx-foyda multiplikatori VEEV (Veeva Systems Inc)|P/E multiplikatori DOCS|HQY - Kapitalizatsiyaning foydaga nisbati|Waystar Health - Narx-foyda koeffitsiyenti|corvel.com (CRVL) - Kapitalizatsiyaning foydaga nisbati|Privia Health Group, Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati HURN (Huron Consulting Group Inc.)|CERT (Certara) - Narx-foyda koeffitsiyenti|OMCL - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati GoodRx Holdings, Inc.|Kapitalizatsiyaning foydaga nisbati Schrodinger, Inc. SDGR|P/E multiplikatori PHR|OMDA (Omada Health) - Kompaniya qiymatining sof foydaga nisbati|Evolent - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati HealthStream, Inc. (HSTM)|Definitive Healthcare Corp - P/E multiplikatori|CCSI - P/E multiplikatori|AGL: P/E multiplikatori|ABSI - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti SY|Kapitalizatsiyaning foydaga nisbati National Research Corp. NRC|Narxning foydaga nisbati Spok (SPOK)|OPRX (OptimizeRx Corporation) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati CPSI TBRG|SLP (Simulations Plus Inc) - Kapitalizatsiyaning sof foydaga nisbati|Sophia Genetics - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Health Catalyst Inc|CCLD (CareCloud, Inc.) - Narx-foyda koeffitsiyenti|RSSS: Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati DLH Corp|Kapitalizatsiyaning foydaga nisbati onemednet.com ONMD|Narxning foydaga nisbati Healthcare Triangle (HCTI)|Biznesning o‘zini qoplash muddati iSpecimen Inc|P/E multiplikatori BFRG (bullfrogai.com)|Biznesning o‘zini qoplash muddati SCWorx (WORX)|MSPR - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati icoreconnect.com ICCT|TRxADE Health Corp (MEDS) - Narxning foydaga nisbati|ORGS - Biznesning o‘zini qoplash muddati|RCM - Kompaniya qiymatining sof foydaga nisbati|SHCR (Sharecare) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Streamline Health (STRM)|P/E multiplikatori Syra Health (SYRA)|P/E multiplikatori AMEH (ApolloMed)|MODN: Narx-foyda multiplikatori|nextgen.com - P/E multiplikatori